Author
Listed:
- Peter S. J. Bailey
(University of Cambridge
Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge)
- Brian M. Ortmann
(University of Cambridge
Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge)
- Anthony W. Martinelli
(Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge)
- Jack W. Houghton
(University of Cambridge)
- Ana S. H. Costa
(MRC Cancer Unit, University of Cambridge
Cold Spring Harbor Laboratory)
- Stephen P. Burr
(University of Cambridge
MRC Mitochondrial Biology Unit, University of Cambridge)
- Robin Antrobus
(University of Cambridge)
- Christian Frezza
(MRC Cancer Unit, University of Cambridge)
- James A. Nathan
(University of Cambridge
Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge)
Abstract
2-oxoglutarate (2-OG or α-ketoglutarate) relates mitochondrial metabolism to cell function by modulating the activity of 2-OG dependent dioxygenases involved in the hypoxia response and DNA/histone modifications. However, metabolic pathways that regulate these oxygen and 2-OG sensitive enzymes remain poorly understood. Here, using CRISPR Cas9 genome-wide mutagenesis to screen for genetic determinants of 2-OG levels, we uncover a redox sensitive mitochondrial lipoylation pathway, dependent on the mitochondrial hydrolase ABHD11, that signals changes in mitochondrial 2-OG metabolism to 2-OG dependent dioxygenase function. ABHD11 loss or inhibition drives a rapid increase in 2-OG levels by impairing lipoylation of the 2-OG dehydrogenase complex (OGDHc)—the rate limiting step for mitochondrial 2-OG metabolism. Rather than facilitating lipoate conjugation, ABHD11 associates with the OGDHc and maintains catalytic activity of lipoyl domain by preventing the formation of lipoyl adducts, highlighting ABHD11 as a regulator of functional lipoylation and 2-OG metabolism.
Suggested Citation
Peter S. J. Bailey & Brian M. Ortmann & Anthony W. Martinelli & Jack W. Houghton & Ana S. H. Costa & Stephen P. Burr & Robin Antrobus & Christian Frezza & James A. Nathan, 2020.
"ABHD11 maintains 2-oxoglutarate metabolism by preserving functional lipoylation of the 2-oxoglutarate dehydrogenase complex,"
Nature Communications, Nature, vol. 11(1), pages 1-15, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-17862-6
DOI: 10.1038/s41467-020-17862-6
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-17862-6. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.